A new anti-viral drug could improve COVID-19 outcomes and survival rates and is highly effective against multiple variants according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.
The drug, called N-0385, blocks the SARS-CoV-2 virus from entering human cells through its favoured cell gateways. The results of the study are under review for publication in a scientific journal and have been uploaded as a preprint….
